Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daikenchuto (TU-100) for Rectal Sensation in IBS
NCT01890837Phase 2Completed
- Sponsor
- Tsumura & Co.
- Start
- Aug 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of daikenchuto in irritable bowel syndrome (IBS), sponsored by Tsumura & Co.. Started Aug 2013; status: completed.
02
Drugs
daikenchuto
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT01890837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01890837.